Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco J Herold

Showing results (1-10 of 159) with videos related to

Pageof 16
Sort By:
The EMBO Journal|January 21, 2014
It's not over until the FAT lady singsMarco J Herold, Andreas Strasser
Biochemical Society Transactions|January 15, 2021
CRISPR base editing applications for identifying cancer-driving mutationsMartin Pal, Marco J Herold
Critical Reviews in Immunology|June 13, 2013
Glucocorticoid-induced apoptosis in animal models of multiple sclerosisMarco J Herold, Holger M Reichardt
Methods in Molecular Biology (Clifton, N.J.)|April 25, 2016
Using CRISPR/Cas9 Technology for Manipulating Cell Death RegulatorsAndrew J Kueh, Marco J Herold
Nature Reviews. Molecular Cell Biology|September 3, 2020
Emerging connectivity of programmed cell death pathways and its physiological implicationsSammy Bedoui, Marco J Herold, Andreas Strasser
Biochemical Society Transactions|July 28, 2022
Last but not least: BFL-1 as an emerging target for anti-cancer therapiesGaoyuan Wang, Sarah T Diepstraten, Marco J Herold
Experimental Cell Research|February 21, 2012
A1/Bfl-1 in leukocyte development and cell deathEleonora Ottina, Denise Tischner, Marco J Herold, et al.
Essays in Biochemistry|April 13, 2022
Case Study: CRISPR 101 - a novel online learning course harnessing innovative ways to teach a complex biomolecular technologyMartin Pal, Nicki Cranna, Marco J Herold, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 9, 2002
Mitochondria-dependent caspase-9 activation is necessary for antigen receptor-mediated effector caspase activation and apoptosis in WEHI 231 lymphoma cellsMarco J Herold, Andreas W Kuss, Christa Kraus, et al.
European Journal of Immunology|February 8, 2018
CRISPR/Cas9: A tool for immunological researchKatharina Hochheiser, Andrew J Kueh, Thomas Gebhardt, et al.
Pageof 16

Showing results (1-10 of 159) with videos related to

Sort By:
Pageof 16
The EMBO Journal|January 21, 2014
It's not over until the FAT lady singsMarco J Herold, Andreas Strasser
Biochemical Society Transactions|January 15, 2021
CRISPR base editing applications for identifying cancer-driving mutationsMartin Pal, Marco J Herold
Critical Reviews in Immunology|June 13, 2013
Glucocorticoid-induced apoptosis in animal models of multiple sclerosisMarco J Herold, Holger M Reichardt
Methods in Molecular Biology (Clifton, N.J.)|April 25, 2016
Using CRISPR/Cas9 Technology for Manipulating Cell Death RegulatorsAndrew J Kueh, Marco J Herold
Nature Reviews. Molecular Cell Biology|September 3, 2020
Emerging connectivity of programmed cell death pathways and its physiological implicationsSammy Bedoui, Marco J Herold, Andreas Strasser
Biochemical Society Transactions|July 28, 2022
Last but not least: BFL-1 as an emerging target for anti-cancer therapiesGaoyuan Wang, Sarah T Diepstraten, Marco J Herold
Experimental Cell Research|February 21, 2012
A1/Bfl-1 in leukocyte development and cell deathEleonora Ottina, Denise Tischner, Marco J Herold, et al.
Essays in Biochemistry|April 13, 2022
Case Study: CRISPR 101 - a novel online learning course harnessing innovative ways to teach a complex biomolecular technologyMartin Pal, Nicki Cranna, Marco J Herold, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 9, 2002
Mitochondria-dependent caspase-9 activation is necessary for antigen receptor-mediated effector caspase activation and apoptosis in WEHI 231 lymphoma cellsMarco J Herold, Andreas W Kuss, Christa Kraus, et al.
European Journal of Immunology|February 8, 2018
CRISPR/Cas9: A tool for immunological researchKatharina Hochheiser, Andrew J Kueh, Thomas Gebhardt, et al.
Pageof 16